SLS
Sellas Life Sciences Group Inc
NASDAQ: SLS · HEALTHCARE · BIOTECHNOLOGY
$4.95
+6.00% today
Updated 2026-04-30
Market cap
$900.52M
P/E ratio
—
P/S ratio
26.90x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$1 – $6
Volume
6.7M
Sellas Life Sciences Group Inc (SLS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |